[go: up one dir, main page]

AU3048689A - Immunogenic peptides - Google Patents

Immunogenic peptides

Info

Publication number
AU3048689A
AU3048689A AU30486/89A AU3048689A AU3048689A AU 3048689 A AU3048689 A AU 3048689A AU 30486/89 A AU30486/89 A AU 30486/89A AU 3048689 A AU3048689 A AU 3048689A AU 3048689 A AU3048689 A AU 3048689A
Authority
AU
Australia
Prior art keywords
immunogenic peptides
immunogenic
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30486/89A
Inventor
Stanley M. Lemon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill filed Critical University of North Carolina at Chapel Hill
Publication of AU3048689A publication Critical patent/AU3048689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU30486/89A 1988-01-13 1989-01-13 Immunogenic peptides Abandoned AU3048689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14339588A 1988-01-13 1988-01-13
US143395 2002-05-10

Publications (1)

Publication Number Publication Date
AU3048689A true AU3048689A (en) 1989-08-11

Family

ID=22503877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30486/89A Abandoned AU3048689A (en) 1988-01-13 1989-01-13 Immunogenic peptides

Country Status (2)

Country Link
AU (1) AU3048689A (en)
WO (1) WO1989006658A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705841A1 (en) * 1994-10-05 1996-04-10 SORIN BIOMEDICA S.p.A. Peptides havng antigenic activity against hepatitis A virus (HAV)
US7223535B2 (en) 1996-04-19 2007-05-29 Centers For Disease Control Synthetic peptides immunoreactive with hepatitis A virus antibodies
EP1200464B1 (en) * 1999-07-15 2006-08-30 The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services Synthetic peptides immunoreactive with hepatitis a virus antibodies
PL201419B1 (en) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Chimeric protein, sequence, construction, vegetable cell, method of obtaining chimeric protein and transgenic plant, transgenic plant, application of transgenic plant and chimeric protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (en) * 1982-10-18 1982-10-18 Bror Morein IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen

Also Published As

Publication number Publication date
WO1989006658A1 (en) 1989-07-27

Similar Documents

Publication Publication Date Title
AU3151689A (en) Improved cryo-slammer
AU3715993A (en) N-isopropylheteroaryloxyacetanilides
AU7956487A (en) Peptide derivatives
AU3098289A (en) Hirudin peptides
AU3362889A (en) Peptide derivatives
AU3480989A (en) Oral preparations
AU3163389A (en) 5-amino-1-phenylpyrazoles
AU3414689A (en) Therapeutic peptides
AU4628489A (en) Assayomate
AU2864489A (en) 16-dehydro-vitamin d3-derivatives
AU3642589A (en) 1-aryl-2-naphthoylamines
AU3977589A (en) Novel peptides
AU4316089A (en) Novel somatotropins
AU4169089A (en) (Diarylmethoxy)-1-pyrrolidines and-piperidines
AU3334389A (en) Rutheniumcomplex-compounds
AU3234289A (en) Co-dispenser
AU3804589A (en) Novel proteins
AU3300089A (en) Triazoloazines
AU3315089A (en) 2-substituted-2-cyclopentenones
AU3869789A (en) Pyrazolo-pyrrolo-pyrimidine-diones
AU3048689A (en) Immunogenic peptides
AU4022589A (en) Vaccinal Polypeptides
AU3508989A (en) Des-17-histidine-calcitonin
AU4679689A (en) Polyhydroxybenzylpxypropanolamines
IL90833A0 (en) Immunogenic peptide